Key Drivers and Opportunities in the Rotavirus Vaccine Market: Insights into Trends and Growth
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Future CAGR of the Rotavirus Vaccine Market, and How Will It Impact Industry Expansion?
In recent periods, the market size of the rotavirus vaccine has experienced rapid expansion. It’s projected that the market will expand from $9.18 billion in 2024 to $10.14 billion in 2025, with a compound annual growth rate (CAGR) of 10.5%. The historic growth can be linked to heightened public awareness about rotavirus, advancements in healthcare infrastructure, initiatives for immunization by the government, an escalated number of rotavirus infections, and increasing birth rates.
Expectations are high for a swift escalation in the size of the rotavirus vaccine market in the upcoming years. It’s projected that by 2029, the market will surge to $14.96 billion, demonstrating a compound annual growth rate (CAGR) of 10.2%. The expansion during the forecast period can be linked to factors like increased birth rates, extension of immunisation programmes, a heightened emphasis on preventative health care, economic development and enhanced accessibility, along with governmental policies and funding. During the same forecast period, key market trends predicted include progressive developments in vaccine technology, oral-dosing techniques, refined vaccine formulations, combination vaccines, and the incorporation of digital health.
How Are the key drivers Contributing to the Expansion of the Rotavirus Vaccine Market?
The anticipated growth of the rotavirus vaccine market is linked to increasing birth rates. Birth rates, typically measured annually, are defined as the amount of live births per 1,000 individuals in a given population. Factors like economic growth and stability, as well as supportive policies like parental leave, child benefits, and subsidies for childcare notably affect the birth rates. The application of rotavirus vaccines mitigates the prevalence of severe rotavirus gastroenteritis in infants, thus enhancing child health results and reducing medical expenses related to rotavirus infections. In January 2023, as per a report by the US based national public health organization, the Centers for Disease Control and Prevention, there was a 1% rise in recorded births in the United States, amounting to 3,664,292 compared to the previous year. Consequently, higher birth rates are likely to fuel the expansion of the rotavirus vaccine market.
Get Your Free Sample of the Global Rotavirus Vaccine Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=20617&type=smp
What Are the Top Market Players Propelling the Growth of the Rotavirus Vaccine Industry?
Major companies operating in the rotavirus vaccine market are:
• Merck & Co. Inc.
• Sanofi S.A.
• Abbott Laboratories
• GlaxoSmithKline plc
• Daiichi Sankyo Company Limited
What Are the Key Trends to Watch in the Rotavirus Vaccine Market Over the Coming Years?
Major players in the rotavirus vaccine market are implementing the use of oral-dosing applicators to improve the process of vaccine administration and to boost patient adherence. These oral-dosing applicators are essentially medical tools that allow for the direct administration of liquid vaccines or medications into the mouth, ensuring precise dosages and better usability, particularly for babies and young children. For example, in November 2022, GSK plc, a pharmaceutical and biotechnology organization based in the UK, was granted approval by the U.S. Food and Drug Administration (FDA) for a new oral-dosing applicator-only ROTARIX (Rotavirus Vaccine, Live, Oral) formulation. This liquid formulation helps prevent rotavirus gastroenteritis resulting from G1 and non-G1 types (G3, G4, and G9) in infants. The new format simplifies the vaccine preparation process for healthcare workers by removing the requirement for dose reconstitution at the point of use.
Get Instant Access to the Global Rotavirus Vaccine Market Report with Swift Delivery!
https://www.thebusinessresearchcompany.com/report/rotavirus-vaccine-global-market-report
Which Key Market Segments Comprise the Rotavirus Vaccine Market and Drive Its Revenue Growth?
The rotavirus vaccine market covered in this report is segmented –
1) By Type: Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, Other Types
2) By Application: Adult, Pediatric
3) By End Users: Hospitals, Clinics, Academic Research
Subsegments:
1) By Rotarix: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics
2) By RotaTeq: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics
3) By Rotavac: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics
4) By Rotavin-M1: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics
5) By Lanzhou Lamb: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics
6) By Other Types: Emerging Rotavirus Vaccines, Combination Vaccines, Region-Specific Vaccines
What Regions Are Dominating the Rotavirus Vaccine Market Growth?
North America was the largest region in the rotavirus vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rotavirus vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Characteristics That Define the Rotavirus Vaccine Market?
The rotavirus vaccine refers to a vaccine designed to protect against rotavirus infections, which are a common cause of severe diarrhea and gastroenteritis in infants and young children. This vaccine is administered orally and contains live attenuated or inactivated strains of the rotavirus to stimulate an immune response and provide immunity against the virus.
Browse Through More Similar Reports By The Business Research Company:
Meningococcal Vaccines Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/meningococcal-vaccines-global-market-report
Swine Vaccines Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/swine-vaccines-global-market-report
Typhoid Vi Polysaccharide Vaccine Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
